12
Participants
Start Date
May 20, 2020
Primary Completion Date
March 22, 2021
Study Completion Date
October 1, 2021
Cannabidiol Oral Solution [Epidiolex]
100 mg BID for three months Placebo oral solution for three months
Silkiss Eye Surgery, Oakland
Collaborators (1)
Benign Essential Blepharospasm Research Foundation
OTHER
GW Pharmaceuticals Ltd
INDUSTRY
Smith-Kettlewell Eye Research Institute
OTHER
Silkiss Eye Surgery
OTHER